The catastrophic fall from grace of the genetic testing app 23 and Me is a salutary lesson for all companies that espouse the use of “big data” in healthcare. Once a leading digital health tech firm, worth $6 billion as recently as 2021, the company is now on the verge of being taken private at […]
What debilitating condition affects 1.5 million women in the UK, and yet takes almost nine years on average to be diagnosed? A condition that – despite the numbers it affects – is so poorly recognised that it is often mistaken for something else, or written off as unimportant? That results in pain so bad it […]
For decades, scientists believed that infections were determined solely by viruses and bacteria, but Professor Jean-Laurent Casanova’s groundbreaking research has revealed a more complex reality. Genes play a fundamental role in determining who gets seriously ill and who stays healthy. Because of his pioneering discoveries, he is being honoured and awarded with the 2025 Novo […]
Access to rare disease medicines will likely always be a fraught issue as healthcare systems seek to balance providing equitable patient care against their finite budgets. Even so-called “universal” healthcare systems, such as the NHS, are often unable to provide expensive rare disease treatments to the patients that need them because of costs and the […]
OZEMPIC, Wegovy, Mounjaro, Zepbound: they’ve quickly become part of our vocabulary. In just a few years, powerful GLP-1 drugs, first introduced to control Type 2 diabetes but now much better known for their ability to help people rapidly lose weight, have become indispensable weapons in the Battle of the Bulge. In the UK alone, some […]
